Persistent severe asthma and aging: step-up therapy with omalizumab to improve control.
Paul A
PA
Greenberger
D000367:Age Factors; D000375:Aging; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000453:epidemiology* / Q000401:mortality; D002986:Clinical Trials as Topic; D006801:Humans; D008875:Middle Aged; D000069444:Omalizumab; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab